Palani Santhosh

Palani Santhosh is listed in filings as Director at Acrivon Therapeutics, Inc. Common Stock. This profile follows SEC Form 4 activity through May 20, 2026, including 4 public disclosures. Recent filings connect the profile to Acrivon Therapeutics, Inc. Common Stock (ACRV) and Pyxis Oncology, Inc. (PYXS). The current snapshot covers public activity from Apr 2, 2025 to May 20, 2026. Reported amounts are shown as $62.4K to $36.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.